| Name | Cvs Pharmacy #00003 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 1497 Route 206, Tabernacle, New Jersey 08088 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (609) 268-0279 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.
Demonstrating the value of standards-based health information technologies, MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is participating as an Implementer in the HIMSS10 Interoperability Showcase at booth #233 in Hall C of the Georgia World Congress Center in Atlanta, Georgia. The Showcase is part of the 2010 Annual Healthcare Information and Management Systems Society Conference & Exhibition being held from March 1-4.
Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk - according to a study of endoscopes used at five hospitals across the U.S.
Mustafa al'Absi, Ph.D., professor of behavioral sciences at the University of Minnesota Medical School - Duluth Campus, and director of the Duluth Medical Research Institute, has received funding and launched a new first-of-its-kind international research initiative: "Khat Research Program: Neurobehavioral Impact of Long-Term Use".
Progression of renal cell carcinoma is frequently preceded by a rise in levels of proangiogenic cytokines, Italian researchers have found.
› Verified 6 days ago
| NPI Number | 1710143342 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #00003 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1497 Route 206, Tabernacle, NJ 08088 |
| Phone Number | 609-268-0279 |
News Archive
A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.
Demonstrating the value of standards-based health information technologies, MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is participating as an Implementer in the HIMSS10 Interoperability Showcase at booth #233 in Hall C of the Georgia World Congress Center in Atlanta, Georgia. The Showcase is part of the 2010 Annual Healthcare Information and Management Systems Society Conference & Exhibition being held from March 1-4.
Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk - according to a study of endoscopes used at five hospitals across the U.S.
Mustafa al'Absi, Ph.D., professor of behavioral sciences at the University of Minnesota Medical School - Duluth Campus, and director of the Duluth Medical Research Institute, has received funding and launched a new first-of-its-kind international research initiative: "Khat Research Program: Neurobehavioral Impact of Long-Term Use".
Progression of renal cell carcinoma is frequently preceded by a rise in levels of proangiogenic cytokines, Italian researchers have found.
› Verified 6 days ago
News Archive
A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.
Demonstrating the value of standards-based health information technologies, MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is participating as an Implementer in the HIMSS10 Interoperability Showcase at booth #233 in Hall C of the Georgia World Congress Center in Atlanta, Georgia. The Showcase is part of the 2010 Annual Healthcare Information and Management Systems Society Conference & Exhibition being held from March 1-4.
Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk - according to a study of endoscopes used at five hospitals across the U.S.
Mustafa al'Absi, Ph.D., professor of behavioral sciences at the University of Minnesota Medical School - Duluth Campus, and director of the Duluth Medical Research Institute, has received funding and launched a new first-of-its-kind international research initiative: "Khat Research Program: Neurobehavioral Impact of Long-Term Use".
Progression of renal cell carcinoma is frequently preceded by a rise in levels of proangiogenic cytokines, Italian researchers have found.
› Verified 6 days ago
Cvs Pharmacy #00003 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1497 Route 206, Tabernacle, New Jersey 08088 Phone: (609) 268-0279 |